
Sign up to save your podcasts
Or


The controversial drug is back in the news. In the early days of the pandemic, President Trump and some doctors touted it as an effective treatment. But studies soon discredited the treatment. Now, in an unexpected twist, some research papers dismissing the drug have also been thrown in doubt. So how useful is Hydroxychloroquine and how reliable are the reviews we rely on to assess a drug's safety? Laura Carlson speaks to Bloomberg reporters Michelle Cortez and Robert Langreth for answers.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
805805 ratings
The controversial drug is back in the news. In the early days of the pandemic, President Trump and some doctors touted it as an effective treatment. But studies soon discredited the treatment. Now, in an unexpected twist, some research papers dismissing the drug have also been thrown in doubt. So how useful is Hydroxychloroquine and how reliable are the reviews we rely on to assess a drug's safety? Laura Carlson speaks to Bloomberg reporters Michelle Cortez and Robert Langreth for answers.
See omnystudio.com/listener for privacy information.

78,613 Listeners

32,196 Listeners

6,801 Listeners

29,047 Listeners

15,457 Listeners

2,690 Listeners

403 Listeners

2,179 Listeners

1,971 Listeners

423 Listeners

12,119 Listeners

17,803 Listeners

969 Listeners

112,664 Listeners

194 Listeners

30 Listeners

10,051 Listeners

4 Listeners

58 Listeners

233 Listeners

228 Listeners

65 Listeners

77 Listeners

82 Listeners

394 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

72 Listeners

1,151 Listeners

186 Listeners